Open AccessVaccinating Children against COVID-19: Commentary and Mathematical Modeling
Author(s) -
Michael Hawkes,
Michael F. Good
Publication year - 2022
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.03789-21
Subject(s) - vaccination , covid-19 , public health , medicine , disease , environmental health , pediatrics , family medicine , virology , infectious disease (medical specialty) , outbreak , pathology
Countries have recently begun implementation of childhood vaccination against SARS-CoV-2 with the Pfizer/BioNTech mRNA vaccine in children 5 to 11 years of age. Because SARS-CoV-2 disease severity is remarkably age dependent, vaccinating children may have modest public health benefits, relative to the unequivocal benefit of vaccinating vulnerable older adults.